North America Hematological Disorders Market Outlook to 2036 – Hematology Tests and Hemostasis Tests

Powered by

All the vital news, analysis, and commentary curated by our industry experts.

$5995
Buy Report

Published: May 30, 2026 Report Code: GDME22066CRDB-ST

Select Item

GlobalData’s “North America Hematological Disorders Market Outlook to 2036” is a comprehensive databook report, covering key market data on the North America Hematological Disorders market. The databook report provides value (USD), volume (units) and average prices (USD) within market segments – Hematology Tests, Hemostasis Tests

The North America Hematological Disorders Market report provides key information and data on –
– Annualized market revenues (USD), volume (units) and average prices (USD) data for each of the market segments. Data is provided from 2024 to 2036.
– 2025 company share data for Hematological Disorders Market.
– Global corporate-level profiles of key companies operating within the North America Hematological Disorders Market. Based on the availability of data for the particular category and country, information related to pipeline products, news and deals is also available in the report.

Scope

North America Hematological Disorders is segmented as follows:

– Hematology Tests

– Hemostasis Tests

Reasons to Buy

The North America Hematological Disorders Market report helps you to develop:

– Business strategies by identifying the key market segments poised for strong growth in the future.

– Market-entry and market expansion strategies.

– Design competition strategies by identifying who-stands-where in the market.

– Develop investment strategies by identifying the key market segments expected to register strong growth in the near future.

Table of Contents

Table of Contents_x000D_

List of Tables_x000D_

List of Figures_x000D_

1 Introduction_x000D_

1.1 What Is This Report About?_x000D_

1.2 Hematological Disorders Market Segmentation_x000D_

1.3 Definitions of Markets Covered in the Report_x000D_

2 Hematological Disorders Market, North America_x000D_

2.1 Hematological Disorders Market, North America, Revenue ($m), 2024-2036_x000D_

2.2 Hematological Disorders Market, North America, Revenue ($m), 2024-2036_x000D_

2.3 Hematological Disorders Market, North America, Volume (Units), 2024-2036_x000D_

2.4 Hematological Disorders Market, North America, Volume (Units), 2024-2036_x000D_

2.5 Hematological Disorders Market, North America, Company Share by Revenue ($m), 2025_x000D_

3 Hematological Disorders Market, Canada_x000D_

3.1 Hematological Disorders Market, Canada, Revenue ($m), 2024-2036_x000D_

3.1.1 Hematology Tests Market, Canada, Revenue ($m), by Segment, 2024-2036_x000D_

3.1.2 Hemostasis Tests Market, Canada, Revenue ($m), by Segment, 2024-2036_x000D_

3.2 Hematological Disorders Market, Canada, Volume (Units), 2024-2036_x000D_

3.2.1 Hematology Tests Market, Canada, Volume (Units), by Segment, 2024-2036_x000D_

3.2.2 Hemostasis Tests Market, Canada, Volume (Units), by Segment, 2024-2036_x000D_

3.3 Hematological Disorders Market, Canada, Average Price ($), 2024-2036_x000D_

3.4 Hematological Disorders Market, Canada, Company Share by Revenue ($m), 2025_x000D_

4 Hematological Disorders Market, Mexico_x000D_

4.1 Hematological Disorders Market, Mexico, Revenue ($m), 2024-2036_x000D_

4.1.1 Hematology Tests Market, Mexico, Revenue ($m), by Segment, 2024-2036_x000D_

4.1.2 Hemostasis Tests Market, Mexico, Revenue ($m), by Segment, 2024-2036_x000D_

4.2 Hematological Disorders Market, Mexico, Volume (Units), 2024-2036_x000D_

4.2.1 Hematology Tests Market, Mexico, Volume (Units), by Segment, 2024-2036_x000D_

4.2.2 Hemostasis Tests Market, Mexico, Volume (Units), by Segment, 2024-2036_x000D_

4.3 Hematological Disorders Market, Mexico, Average Price ($), 2024-2036_x000D_

4.4 Hematological Disorders Market, Mexico, Company Share by Revenue ($m), 2025_x000D_

5 Hematological Disorders Market, United States_x000D_

5.1 Hematological Disorders Market, United States, Revenue ($m), 2024-2036_x000D_

5.1.1 Hematology Tests Market, United States, Revenue ($m), by Segment, 2024-2036_x000D_

5.1.2 Hemostasis Tests Market, United States, Revenue ($m), by Segment, 2024-2036_x000D_

5.2 Hematological Disorders Market, United States, Volume (Units), 2024-2036_x000D_

5.2.1 Hematology Tests Market, United States, Volume (Units), by Segment, 2024-2036_x000D_

5.2.2 Hemostasis Tests Market, United States, Volume (Units), by Segment, 2024-2036_x000D_

5.3 Hematological Disorders Market, United States, Average Price ($), 2024-2036_x000D_

5.4 Hematological Disorders Market, United States, Company Share by Revenue ($m), 2025_x000D_

6 Hematological Disorders Market Pipeline Products_x000D_

6.1 Hematological Disorders Market Pipeline Products_x000D_

6.2 Hematological Disorders – Pipeline Products by Stage of Development_x000D_

6.3 Hematological Disorders – Pipeline Products by Segment_x000D_

6.4 Hematological Disorders – Pipeline Products by Territory_x000D_

6.5 Hematological Disorders – Pipeline Products by Regulatory Path_x000D_

6.6 Hematological Disorders – Pipeline Products by Estimated Approval Date_x000D_

7 Overview of Key Companies in North America Hematological Disorders Market_x000D_

7.1 Abbott Laboratories_x000D_

7.1.1 Company Overview_x000D_

7.2 Roche Diagnostics International Ltd_x000D_

7.2.1 Company Overview_x000D_

7.3 Sysmex Corp_x000D_

7.3.1 Company Overview_x000D_

7.4 Siemens AG_x000D_

7.4.1 Company Overview_x000D_

7.5 Instrumentation Laboratory Co_x000D_

7.5.1 Company Overview_x000D_

7.6 Diagnostica Stago SAS_x000D_

7.6.1 Company Overview_x000D_

7.7 Beckman Coulter Inc_x000D_

7.7.1 Company Overview_x000D_

7.8 Quidel Corp_x000D_

7.8.1 Company Overview_x000D_

7.9 Radiometer Medical ApS_x000D_

7.9.1 Company Overview_x000D_

7.10 Thermo Fisher Scientific Inc_x000D_

7.10.1 Company Overview_x000D_

8 Recent Developments_x000D_

8.1 Corporate Communications_x000D_

8.1.1 May 18, 2026: Texas Children’s Faculty Receive More Than $5.6M in Research Grants_x000D_

8.1.2 Nov 20, 2025: Quanterix Announces Board and Leadership Changes_x000D_

8.1.3 Nov 13, 2025: Cleveland Clinic Pitch Competition Awards $100,000 Grant to AutoCMR Inventors_x000D_

8.1.4 Nov 12, 2025: Pillar Biosciences Launches New NGS Panel for Tumor Profiling of Lymphoid Malignancies_x000D_

8.1.5 Nov 06, 2025: TEDCO Signs Agreement for Up to $50 Million Investment with TAIIDA and SFIC Group_x000D_

8.1.6 Nov 05, 2025: IU Fuels Indiana’s Next Wave of Industry Growth_x000D_

8.1.7 Nov 01, 2025: Dale Medical Products, Inc. Introduces IV Line Manager_x000D_

8.1.8 Oct 29, 2025: Regenerative Medicine Also Known As Stem Cell Therapy_x000D_

8.1.9 Oct 28, 2025: EMulate Therapeutics Launches Community Investment Round on Wefunder_x000D_

8.1.10 Oct 28, 2025: Tanenbaum Institute for Science in Sport and Saint-Étienne University Hospital Collaborate on Sport and Health Research_x000D_

8.1.11 Oct 21, 2025: Plus Therapeutics Provides Update on CNSide Diagnostic Platform Launch_x000D_

8.1.12 Oct 20, 2025: SRI Multi-Party Team Selected as Awardee by ARPA-H to Develop At-Home Screening for 30 Types of Cancers_x000D_

8.1.13 Oct 08, 2025: Virogates A/S Announces Public Tender Offer to Shareholders_x000D_

8.1.14 Oct 01, 2025: Predicta Biosciences Raises $23.4M to Expand Diagnostic Platform for Blood Cancers_x000D_

8.1.15 Oct 01, 2025: Castle Biosciences’ Derek Maetzold Named CEO of the Year by The CEO Magazine_x000D_

8.1.16 Sep 23, 2025: Pictor Secures Funding for U.S. Expansion Through Proteomics Solutions_x000D_

8.1.17 Sep 15, 2025: Mdxhealth Completes Acquisition of Exosome Diagnostics from Bio-Techne_x000D_

8.2 Government and Public Interest_x000D_

8.2.1 Nov 24, 2025: Adaptive Biotechnologies to Present Nearly 90 Abstracts Featuring clonoSEQ MRD Testing at 67th ASH Meeting_x000D_

8.2.2 Nov 13, 2025: Telo Genomics to Present Individual-Cell Risk Assessment MRD Technology at Myeloma Canada Summit_x000D_

8.3 Other Significant Developments_x000D_

8.3.1 Nov 17, 2025: Inmedix CloudHRV System Surpasses 1000 Procedures in Its First 5 Months_x000D_

8.3.2 Nov 13, 2025: Cleveland Clinic Pitch Competition Awards $100,000 Grant to AutoCMR Inventors_x000D_

8.3.3 Nov 05, 2025: YD Bio and EG BioMed Expand U.S. Access to OkaiDx for Breast Cancer Monitoring_x000D_

8.3.4 Nov 05, 2025: IU Fuels Indiana’s Next Wave of Industry Growth_x000D_

8.3.5 Oct 30, 2025: Refurbished Vs New Immulite 2000Xpi: Which Is Better for Your Lab_x000D_

8.3.6 Oct 28, 2025: Tanenbaum Institute for Science in Sport and Saint-Étienne University Hospital Collaborate on Sport and Health Research_x000D_

8.3.7 Oct 21, 2025: Plus Therapeutics Provides Update on CNSide Diagnostic Platform Launch_x000D_

8.3.8 Oct 20, 2025: SRI Multi-Party Team Selected as Awardee by ARPA-H to Develop At-Home Screening for 30 Types of Cancers_x000D_

8.3.9 Oct 08, 2025: Virogates A/S Announces Public Tender Offer to Shareholders_x000D_

8.3.10 Sep 19, 2025: NDSU Annual Research Awards Total $93.5 Million_x000D_

8.4 Product News_x000D_

8.4.1 Nov 28, 2025: Mike Bako and RENPHO Showcase Health Technology on YourUpdateTV_x000D_

8.4.2 Nov 24, 2025: Adaptive Biotechnologies to Present Nearly 90 Abstracts Featuring clonoSEQ MRD Testing at 67th ASH Meeting_x000D_

8.4.3 Nov 17, 2025: Inmedix CloudHRV System Surpasses 1000 Procedures in Its First 5 Months_x000D_

8.4.4 Nov 13, 2025: Telo Genomics to Present Individual-Cell Risk Assessment MRD Technology at Myeloma Canada Summit_x000D_

8.4.5 Nov 13, 2025: Single Digit Parts Per Million Detection of Molecular Residual Disease Through Integrated Tumor-Informed Whole-Genome Sequencing Analysis_x000D_

8.4.6 Nov 05, 2025: YD Bio and EG BioMed Expand U.S. Access to OkaiDx for Breast Cancer Monitoring_x000D_

8.4.7 Oct 30, 2025: Refurbished Vs New Immulite 2000Xpi: Which Is Better for Your Lab_x000D_

8.4.8 Oct 28, 2025: Arima Genomics Study Shows Aventa Lymphoma Test Resolves Diagnostic Ambiguity in B-Cell Lymphoma_x000D_

8.4.9 Oct 28, 2025: EMulate Therapeutics Launches Community Investment Round on Wefunder_x000D_

8.4.10 Oct 21, 2025: Plus Therapeutics Provides Update on CNSide Diagnostic Platform Launch_x000D_

8.4.11 Oct 20, 2025: SRI Multi-Party Team Selected as Awardee by ARPA-H to Develop At-Home Screening for 30 Types of Cancers_x000D_

8.4.12 Oct 09, 2025: American Society of Hematology Accepts Telo Genomics' Abstract for Presentation at 2025 Meeting_x000D_

8.4.13 Oct 02, 2025: Hologic Receives FDA Clearance And CE Mark For Automated Molecular Tests To Detect Infectious Gastroenteritis_x000D_

8.4.14 Oct 01, 2025: Predicta Biosciences Raises $23.4M to Expand Diagnostic Platform for Blood Cancers_x000D_

8.5 Research And Development_x000D_

8.5.1 Feb 04, 2026: Advancing Early Detection for Kidney Disease in Sickle Cell_x000D_

8.6 Strategy And Business Planning_x000D_

8.6.1 Mar 13, 2026: University Hospitals to Build Modern Pathology Laboratory_x000D_

8.6.2 Nov 06, 2025: TEDCO Signs Agreement for Up to $50 Million Investment with TAIIDA and SFIC Group_x000D_

8.6.3 Nov 05, 2025: JLL Partners Announces Combination of Vascular Technology Incorporated and Parks Medical Electronics_x000D_

8.6.4 Oct 28, 2025: Tanenbaum Institute for Science in Sport and Saint-Étienne University Hospital Collaborate on Sport and Health Research_x000D_

8.6.5 Oct 14, 2025: START, Together With HM Hospitales, Inaugurates Spain’s First Pediatric Onco-Hematology Clinical Research Unit_x000D_

8.6.6 Oct 02, 2025: AIxMed And Biopticka Laborator Announce Strategic Collaboration On AI-Cytology In Europe_x000D_

8.6.7 Sep 23, 2025: Pictor Secures Funding for U.S. Expansion Through Proteomics Solutions_x000D_

9 Appendix_x000D_

9.1 Research Methodology_x000D_

9.1.1 Coverage_x000D_

9.1.2 Secondary Research_x000D_

9.1.3 Primary Research_x000D_

9.1.4 Market Modeling and Forecasting_x000D_

9.1.5 Company Share Analysis_x000D_

9.1.6 Benchmarking_x000D_

9.2 GlobalData Consulting_x000D_

9.3 Contact Us_x000D_

9.4 Disclaimer

Table

Table 1: Hematological Disorders Market, Cross Country Comparison, North America, Revenue ($m), USD Constant, 2024-2036

Table 2: Hematological Disorders Market, North America, Revenue ($m), USD Constant, 2024-2036

Table 3: Hematological Disorders Market, North America, Volume (Units), 2024-2036

Table 4: Hematological Disorders Market, North America, Volume (Units), 2024-2036

Table 5: Hematological Disorders Market, North America, Company Share by Revenue ($m), 2025

Table 6: Hematological Disorders Market, Canada, Revenue ($m), USD Constant, 2024-2036

Table 7: Hematology Tests Market, Canada, Revenue ($m), USD Constant, 2024-2036

Table 8: Hemostasis Tests Market, Canada, Revenue ($m), USD Constant, 2024-2036

Table 9: Hematological Disorders Market, Canada, Volume (Units), 2024-2036

Table 10: Hematology Tests Market, Canada, Volume (Units), 2024-2036

Table 11: Hemostasis Tests Market, Canada, Volume (Units), 2024-2036

Table 12: Hematological Disorders Market, Canada, Average Price ($), 2024-2036

Table 13: Hematological Disorders Market, Canada, Company Share by Revenue ($m), USD Constant, 2025

Table 14: Hematological Disorders Market, Mexico, Revenue ($m), USD Constant, 2024-2036

Table 15: Hematology Tests Market, Mexico, Revenue ($m), USD Constant, 2024-2036

Table 16: Hemostasis Tests Market, Mexico, Revenue ($m), USD Constant, 2024-2036

Table 17: Hematological Disorders Market, Mexico, Volume (Units), 2024-2036

Table 18: Hematology Tests Market, Mexico, Volume (Units), 2024-2036

Table 19: Hemostasis Tests Market, Mexico, Volume (Units), 2024-2036

Table 20: Hematological Disorders Market, Mexico, Average Price ($), 2024-2036

Table 21: Hematological Disorders Market, Mexico, Company Share by Revenue ($m), USD Constant, 2025

Table 22: Hematological Disorders Market, United States, Revenue ($m), USD Constant, 2024-2036

Table 23: Hematology Tests Market, United States, Revenue ($m), USD Constant, 2024-2036

Table 24: Hemostasis Tests Market, United States, Revenue ($m), USD Constant, 2024-2036

Table 25: Hematological Disorders Market, United States, Volume (Units), 2024-2036

Table 26: Hematology Tests Market, United States, Volume (Units), 2024-2036

Table 27: Hemostasis Tests Market, United States, Volume (Units), 2024-2036

Table 28: Hematological Disorders Market, United States, Average Price ($), 2024-2036

Table 29: Hematological Disorders Market, United States, Company Share by Revenue ($m), USD Constant, 2025

Table 30: Hematological Disorders Market Pipeline Products

Table 31: Hematological Disorders – Pipeline Products by Stage of Development

Table 32: Hematological Disorders Companies – Pipeline Products by Stage of Development

Table 33: Hematological Disorders – Pipeline Products by Segment

Table 34: Hematological Disorders – Pipeline Products by Territory

Table 35: Hematological Disorders – Pipeline Products by Regulatory Path

Table 36: Hematological Disorders – Pipeline Products by Estimated Approval Date

Table 37: Total Number of Primary Research Participants, In Vitro Diagnostics Market, by Country

Figures

Figure 1: Hematological Disorders Market, Cross Country Comparison, North America, Revenue ($m), USD Constant, 2024-2036

Figure 2: Hematological Disorders Market, North America, Revenue ($m), USD Constant, 2024-2036

Figure 3: Hematological Disorders Market, North America, Volume (Units), 2024-2036

Figure 4: Hematological Disorders Market, North America, Volume (Units), 2024-2036

Figure 5: Hematological Disorders Market, North America, Company Share (%), 2025

Figure 6: Hematological Disorders Market, Canada, Revenue ($m), USD Constant, 2024-2036

Figure 7: Hematology Tests Market, Canada, Revenue ($m), USD Constant, 2024-2036

Figure 8: Hemostasis Tests Market, Canada, Revenue ($m), USD Constant, 2024-2036

Figure 9: Hematological Disorders Market, Canada, Volume (Units), 2024-2036

Figure 10: Hematology Tests Market, Canada, Volume (Units), 2024-2036

Figure 11: Hemostasis Tests Market, Canada, Volume (Units), 2024-2036

Figure 12: Hematological Disorders Market, Canada, Company Share (%), 2025

Figure 13: Hematological Disorders Market, Mexico, Revenue ($m), USD Constant, 2024-2036

Figure 14: Hematology Tests Market, Mexico, Revenue ($m), USD Constant, 2024-2036

Figure 15: Hemostasis Tests Market, Mexico, Revenue ($m), USD Constant, 2024-2036

Figure 16: Hematological Disorders Market, Mexico, Volume (Units), 2024-2036

Figure 17: Hematology Tests Market, Mexico, Volume (Units), 2024-2036

Figure 18: Hemostasis Tests Market, Mexico, Volume (Units), 2024-2036

Figure 19: Hematological Disorders Market, Mexico, Company Share (%), 2025

Figure 20: Hematological Disorders Market, United States, Revenue ($m), USD Constant, 2024-2036

Figure 21: Hematology Tests Market, United States, Revenue ($m), USD Constant, 2024-2036

Figure 22: Hemostasis Tests Market, United States, Revenue ($m), USD Constant, 2024-2036

Figure 23: Hematological Disorders Market, United States, Volume (Units), 2024-2036

Figure 24: Hematology Tests Market, United States, Volume (Units), 2024-2036

Figure 25: Hemostasis Tests Market, United States, Volume (Units), 2024-2036

Figure 26: Hematological Disorders Market, United States, Company Share (%), 2025

Figure 27: Hematological Disorders – Pipeline Products by Stage of Development

Figure 28: Hematological Disorders – Pipeline Products by Segment

Figure 29: Hematological Disorders – Pipeline Products by Territory

Figure 30: Hematological Disorders – Pipeline Products by Regulatory Path

Figure 31: Hematological Disorders – Pipeline Products by Estimated Approval Date

North America Hematological Disorders Market Outlook to 2036 – Hematology Tests and Hemostasis Tests standard reports
Currency USD
$5,995

Can be used by individual purchaser only

Most Popular
$11,990

Can be shared by unlimited users within one corporate location e.g. a regional office

$17,985

Can be shared globally by unlimited users within the purchasing corporation e.g. all employees of a single company

Add to Basket

Undecided about purchasing this report?

Enquire Before Buying

Get in touch to find out about multi-purchase discounts

reportstore@globaldata.com
Tel +44 20 7947 2745

See what our customers are saying
testimonial-image
testimonial-image
testimonial-image
testimonial-image
testimonial-image
testimonial-image
testimonial-image

“The GlobalData platform is our go-to tool for intelligence services. GlobalData provides an easy way to access comprehensive intelligence data around multiple sectors, which essentially makes it a one-for-all intelligence platform, for tendering and approaching customers.

GlobalData is very customer orientated, with a high degree of personalised services, which benefits everyday use. The highly detailed project intelligence and forecast reports can be utilised across multiple departments and workflow scopes, from operational to strategic level, and often support strategic decisions. GlobalData Analytics and visualisation solutions has contributed positively when preparing management presentations and strategic papers.”

 Business Intelligence & Marketing Manager, SAL Heavy Lift

“COVID-19 has caused significant interference to our business and the COVID-19 intelligence from GlobalData has helped us reach better decisions around strategy. These two highlights have helped enormously to understand the projections into the future concerning our business units, we also utilise the project database to source new projects for Liebherr-Werk to use as an additional source to pitch for new business.”

 Market Analyst & Management, Liebherr-Werk

Your daily news has saved me a lot of time and keeps me up-to-date with what is happening in the market, I like that you almost always have a link to the source origin. We also use your market data in our Strategic Business Process to support our business decisions. By having everything in one place on the Intelligence Center it has saved me a lot of time versus looking on different sources, the alert function also helps with this.

 Head of Key Accounts, Saab AB

Having used several other market research companies, I find that GlobalData manages to provide that ‘difficult-to-get’ market data that others can’t, as well as very diverse and complete consumer surveys.

 Marketing Intelligence Manager, Portugal Foods

Our experience with GlobalData has been very good, from the platform itself to the people. I find that the analysts and the account team have a high level of customer focus and responsiveness and therefore I can always rely on. The platform is more holistic than other providers. It is convenient and almost like a one stop shop. The pricing suite is highly competitive and value for our organisation.

I like reports that inform new segments such as the analysis on generation Z, millennials, the impact of COVID 19 to our banking customers and their new channel habits. Secondly the specialist insight on affluent sector significantly increases our understanding about this group of customers. The combination of those give us depth and breadth of the evolving market.

I’m in the business of answering and helping people make decisions so with the intelligence center I can do that, effectively and efficiently. I can share quickly key insights that answer and satisfy our country stakeholders by giving them many quality studies and primary research about competitive landscape beyond the outlook of our bank. It helps me be seen as an advisory partner and that makes a big difference. A big benefit of our subscription is that no one holds the whole data and because it allows so many people, so many different parts of our organisation have access, it enables all teams to have the same level of knowledge and decision support.

 Head of Customer Insight and Research, Standard Chartered

“I know that I can always rely on Globaldata’s work when I’m searching for the right consumer and market insights. I use Globaldata insights to understand the changing market & consumer landscape and help create better taste & wellbeing solutions for our customers in food, beverage and healthcare industries.

Globaldata has the right data and the reports are of very high quality compared to your competitors. Globaldata not only has overall market sizes & consumer insights on food & beverages but also provides insights at the ingredient & flavour level. That is key for B2B companies like Givaudan. This way we understand our customers’ business and also gain insight to our unique industry”

 Head of Consumer Sensory Insights, Givaudan

GlobalData provides a great range of information and reports on various sectors that is highly relevant, timely, easy to access and utilise.  The reports and data dashboards help engagement with clients; they provide valuable industry and market insights that can enrich client conversations and can help in the shaping of value propositions. Moreover, using GlobalData products has helped increase my knowledge of the finance sector, the players within it, and the general threats and opportunities.

I find the consumer surveys that are carried out to be extremely beneficial and not something I have seen anywhere else. They provided an insightful view of why and which consumers take (or don’t) particular financial products. This can help shape conversations with clients to ensure they make the right strategic decisions for their business.

One of the challenges I have found is that data in the payments space is often piecemeal. With GD all of the data I need is in one place, but it also comes with additional market reports that provide useful extra context and information. Having the ability to set-up alerts on relevant movements in the industry, be it competitors or customers, and have them emailed directly to me, ensures I get early sight of industry activity and don’t have to search for news.

 Senior Account Manager, TSYS

Related reports

View more In Vitro Diagnostics reports
Medical Devices
New
Global M&A Deals in H1 2026 - Top Themes by…
$495 | August 2026
Medical Devices
New
Medical Devices M&A Deals H1 2026 - Top Themes: Strategic…
$495 | July 2026
Medical Devices
New
AI-designed Materials: Market Trends and Innovations
$995 | July 2026
Go even deeper with GlobalData Intelligence Center

Every Company Report we produce is powered by the GlobalData Intelligence Center.

Subscribing to our intelligence platform means you can monitor developments at North America Hematological Disorders Market Outlook to 2036 – Hematology Tests and Hemostasis Tests in real time.

  • Access a live North America Hematological Disorders Market Outlook to 2036 – Hematology Tests and Hemostasis Tests dashboard for 12 months, with up-to-the-minute insights.
  • Fuel your decision making with real-time deal coverage and media activity.
  • Turn insights on financials, deals, products and pipelines into powerful agents of commercial advantage.
Tell me more